Radmila Faizova

Radmila Faizova is an accomplished professional in the field of chemistry, currently serving as a Project Leader at Paul Scherrer Institut PSI, where the focus is on developing novel 225Ac/18F targeted 'theranostic' agents. Concurrently, Radmila holds the position of Senior Research Associate at Kielo Research, specializing in scientific health preference and outcome studies. Prior to these roles, Radmila completed a postdoctoral fellowship at CHUV | Lausanne University Hospital, concentrating on diagnostic PET imaging platforms for cancer immunotherapy. Radmila's educational background includes a PhD in Chemistry from EPFL and an MSc from the University of Nottingham, complemented by diverse experiences in companies such as Novartis and Actelion, contributing to both academic and practical advancements in the chemistry field.